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Abstract
Using targeted exome sequencing we identified mutations in NNT, an antioxidant defence gene, in
patients with familial glucocorticoid deficiency. In mice with Nnt loss, higher levels of
adrenocortical cell apoptosis and impaired glucocorticoid production were observed. NNT
knockdown in a human adrenocortical cell line resulted in impaired redox potential and increased
ROS levels. Our results suggest that NNT may have a role in ROS detoxification in human adrenal
glands.
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Familial Glucocorticoid Deficiency (FGD;OMIM 202200) is a rare autosomal recessive
disorder characterized by an inability of the adrenal cortex to produce cortisol in response to
stimulation by adrenocorticotropin hormone (ACTH). Patients typically present within the
first few months of life with symptoms related to cortisol deficiency including recurrent
illnesses/infections, hypoglycaemia, convulsions, failure to thrive and shock. The disease is
life-threatening if untreated. 50% of FGD cases are caused by mutations in one of three
genes; MC2R, MRAP or STAR, all encoding components of the ACTH signaling -
steroidogenic pathway [1-3].
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To search for further causal genes in FGD we carried out SNP array genotyping using the
GeneChip Human Mapping 10K Array Xba142 (Affymetrix) in 9 probands from
consanguineous families with FGD of unknown aetiology. Data analysis identified a
candidate region, 5p13-q12 with linkage to 3 families (maximum HLOD score of 2.34).
Genotyping of microsatellite markers confirmed homozygosity in this region only in
affected family members and not in parents or unaffected siblings. Targeted exome
sequencing of the proband from one kindred with chromosome 5-linkage identified 717
variants from the Feb. 2009 (NCBI37/hg19) human reference sequence assembly.
Application of a filtration strategy (see methods) reduced the number of variants for
validation to 5 (Supplementary Table 1). Only 1 variant, (c.1598C>T;p.Ala533Val) in
nicotinamide nucleotide transhydrogenase (NNT) was homozygous in the affected patient,
heterozygous in his parents and absent in controls (Supplementary Figure 1A). Homozygous
NNT mutations, c.600-1delG at the splice junction of intron 4/exon 5 (predicted
consequence p.Tyr201PhefsX2) and c.2930T>C; p.Leu977Pro within exon 20, were
discovered in the two other chromosome 5-linked families (Supplementary Figure 1B). 18
further mutations in 12 kindreds were found in homozygosity or compound heterozygosity
on sequencing of 100 patients with FGD of unknown cause (Table 1 and supplementary
Figures 1[C&D] and 2). These mutations were spread throughout the gene and included
abolition of the initiating methionine, two further splice mutations and many mis- and
nonsense changes. No NNT mutations have previously been described in humans and none
of the reported variants have been annotated in any SNP or mutation database including the
1000 genomes project and the NHLBI grand opportunity exome sequencing project in which
>5,000 exomes have been sequenced [see URLs].
Mutation of the initiating methionine is of unknown consequence as the next methionine is
at residue 132, and initiation of translation from this codon would result in a protein lacking
the whole mitochondrial targeting presequence. Many of the described mutations are
nonsense/frameshift and will lead to premature truncation of the protein. The remaining
missense mutations, with the exception of the H365P substitution, are predicted to cause
disruption to vital, highly conserved eukaryotic protein domains.
NNT, a highly conserved gene, encodes an integral protein of the inner mitochondrial
membrane. Under most physiological conditions, this enzyme uses energy from the
mitochondrial proton gradient to produce high concentrations of NADPH. Detoxification in
mitochondria of reactive oxygen species (ROS) by glutathione peroxidases depends on this
NADPH for regeneration of reduced glutathione (GSH) from oxidized glutathione (GSSG)
to maintain a high GSH/GSSG ratio (Supplementary Figure 3). Arkblad et al. showed that C.
elegans lacking nnt-1 either through mutation or RNAi knockdown are more susceptible to
oxidative stress (OS) because of a lowered GSH/GSSG ratio [4]. Certain sub-strains of
C57BL/6J mice contain a spontaneous Nnt mutation (an in-frame 5 exon deletion), and have
been reported to display glucose intolerance and reduced insulin secretion [5,6]. Knockdown
of NNT in human PC12 phaeochromocytoma cells results in decreased cellular NADPH,
decreased GSH/GSSG ratios, increased H2O2 levels and hence impaired redox homeostasis
[7].
Adrenals from 3 month C57BL6/J mice carrying the Nnt mutation had slightly disorganized
zonae fasciculata with higher levels of apoptosis than wild-type, C57BL6/NHsd, mice
(Figures 1A & B). There were no observable differences between levels of the steroidogenic
URLs
1000 Genomes, http://www.1000genomes.org/
Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/) [January
2012 accessed].
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enzymes CYP11A1 and CYP11B1 between the two substrains however the mutant mice did
have lower basal and stimulated levels of corticosterone than their wild-type counterparts
(Figure 1A & C). Knockdown of NNT in the human adrenocortical H295R cell line by
shRNA not only increased levels of mitochondrial ROS and apoptosis but also lowered the
GSH/GSSG ratio (29.95±4.77 vs 18.82±8.75 in scrambled vs knockdown cells; p<0.001)
implying these cells also have an impaired redox potential (Figure 1D-G and supplementary
Figure 4). We found NNT to be widely expressed and most readily detectable in human
adrenal, heart, kidney, thyroid and adipose tissue (Supplementary Figure 5) similar to
murine expression profiles [8-10].
These findings suggest that the impairment of adrenal steroidogenesis and development of
FGD is due to defective OS responses. OS has been implicated in the pathogenesis of many
disease conditions. Of particular relevance to our patients is Triple A syndrome (OMIM
231550) [11]. In this condition mutations in AAAS lead to deficiency or mislocalization of
the nuclear-pore protein ALADIN resulting in impairment of the nuclear import of DNA
repair and antioxidant proteins [12,13] thereby rendering the patients cells more susceptible
to OS. AAAS-/- mice however show no such phenotype [14]. Nnt loss in mice has been
reported to lead to impaired insulin secretion and glucose-intolerance because of OS in
pancreatic beta cells [5]. Although no adrenal phenotype has previously been documented in
these mice, our studies hint at a mild deficit in adrenal steroidogenesis. In conclusion our
results suggest that, at least in humans, NNT is of primary importance for ROS
detoxification in adrenocortical cells, highlighting the susceptibility of the adrenal cortex to
this type of pathological damage. Over time patients may develop other organ pathologies
related to impaired anti-oxidant defence and will therefore need careful monitoring.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Knockout or knockdown of NNT increases levels of mitochondrial ROS and apoptosis. A
Adrenal zonation and steroidogenesis in 6NHsd and 6J mice. Wt and Nnt mutant mice
showed similar patterns of CYP11A1 (red) and -B1 (green) staining, indicating no
significant differences in zonation or steroidogenic capacity. The ZF cells in 6J mice
however are slightly hyperplastic and disorganised being more densely packed and lacking
the linear architecture seen in wt ZF. 40× magnification. B Increased apoptosis in 6J mice.
Adrenals from 6J showed a higher number of caspase 3 positive cells (red) in zona
fasciculata than 6NHsd. C Corticosterone levels in 6NHsd and 6J mouse serum stimulated
with ACTH. Radioimmunoassay results revealed both basal and stimulated corticosterone
levels were lower in 6J (p< 0.05). D Stable NNT knockdown (NNT-KD) in H295R cells.
RT-PCR (i) and western blot analysis (ii) confirmed knockdown of NNT mRNA (71%) and
protein (78%) levels in KD compared to SCR. E Detection of superoxide production by
Mitosox. Quantitative analysis showed a significant increase (p<0.005) in superoxide
production in NNT-KD relative to SCR cells. F Densitometric analysis showed a significant
(p<0.001) increase in cleaved PARP between SCR and NNT-KD cells. Values are
intensities of cleaved PARP relative to actin, n=12. G The GSH/GSSG ratio was lower in
NNT-KD vs SCR cells (p<0.001). OS induced by the addition of 40μM menadione to the
SCR cells reduced the ratio to 0.69±0.67.
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